Axogen, Inc. — Director's Dealing 2023

Mar 30, 2023

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2023-03-20

Reporting Person: Began Marc A (EVP & General Counsel)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Restricted Stock Units	$0.0		Common Stock (45000.0)		Direct
Employee Stock Option (right to purchase)	$8.16	2033-03-01	Common Stock (90000.0)		Direct

Footnotes

F1: All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 1, 2027 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 1, 2025 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.